Single-dose versus short-course prophylactic antibiotics for peroral endoscopic myotomy: a randomized controlled

Roberta Maselli1, Alessandra Oliva2, Matteo Badalamenti3

  • 1Department of Biomedical Sciences, Humanitas University, Milan, Italy; Digestive Endoscopy Unit, Division of Gastroenterology, IRCCS Humanitas Research Hospital, Milan, Italy.

Abstract

Insights

Post-POEM antibiotic therapy is not necessary for achalasia patients. This study found no significant difference in infective risk markers between patients receiving prophylaxis alone versus prophylaxis plus short-term antibiotics, indicating low residual risk.

Area of Science:

  • Gastroenterology
  • Surgical Innovation
  • Infectious Disease Management

Background:

  • Peroral endoscopic myotomy (POEM) is a recommended treatment for achalasia.
  • Antibiotic prophylaxis is standard for POEM, but post-procedure therapy needs are unclear.
  • This study investigates the necessity of additional antibiotic therapy after POEM.

Purpose of the Study:

  • To determine if short-term antibiotic therapy is required after POEM in addition to prophylaxis.
  • To assess infective risk by monitoring host response, immune markers, and blood cultures.

Main Methods:

  • Randomized controlled trial comparing antibiotic prophylaxis alone (Group A) versus prophylaxis plus short-term oral antibiotics (Group B).
  • Infective risk assessed via body temperature, white blood cells, C-reactive protein, IL-6, IL-1β, TNF-α, LBP, sCD14, and blood cultures.
  • Data collected at baseline (t0) and post-procedure time points (t1, t2).

Main Results:

  • No significant differences in fever, systemic inflammation markers (CRP, WBC), or immune response cytokines (IL-6, IL-1β, TNF-α) between groups.
  • Microbial translocation markers (LBP, sCD14) were similar between groups.
  • Blood cultures showed no significant difference in bacteremia rates (1.6% vs 3.2%), with all cultures negative at the final time point.

Conclusions:

  • Postprocedural short-term antimicrobial therapy after POEM is not required.
  • The residual infective risk following POEM is very low, even without extended antibiotic courses.
  • Findings support current guidelines and inform clinical practice regarding antibiotic use post-POEM.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
681
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
203
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
46
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
1.3K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
876
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
247